Premium
P3‐172: Identification and validation of novel cerebrospinal fluid protein biomarkers for early Alzheimer's disease using proteomics and ELISA: a multi‐institutional collaborative study
Author(s) -
Perrin Richard J.,
Craig-Schapiro Rebecca,
Malone James P.,
Roe Catherine M.,
Grant Elizabeth A.,
Shah Aarti R.,
Gilmore Petra,
Davis Alan E.,
Peskind Elaine R.,
Li Ge,
Galasko Douglas R.,
Quinn Joseph F.,
Kaye Jeffrey A.,
Clark Christopher M.,
Morris John C.,
Holtzman David M.,
Townsend R. Reid,
Fagan Anne M.
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.1670
Subject(s) - cerebrospinal fluid , proteomics , alzheimer's disease , biomarker , dementia , pathology , disease , cystatin , chemistry , pathological , transthyretin , medicine , cystatin c , biochemistry , gene , renal function
Disease Research Center, University of Washington Medical Center, Seattle, WA, USA; Choju Medical Institute, Fukushimura Hospital, Toyohashi, Japan; Immuno-Biological Laboratories Co., Ltd. (IBL), Fujioka, Japan; Department of Neurology, Emory Alzheimer’s Disease Research Center, Emory University, Atlanta, GA, USA; Department of Neurology, Oregon Health & Science University, Portland, OR, USA; Departments of Neurology and Neuropathology, University of Washington, Seattle, WA, USA; Department of Psychiatry, Alzheimer’s Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA; Departments of Neurology and Psychiatry, Mount Sinai School of Medicine, Alzheimer’s Disease Research Center, New York, NY, USA. Contact e-mail: sahata07@ hotmail.com